Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Charles A Baker. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Charles A Baker har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 7 439 |
US:PGNX / Progenics Pharmaceuticals, Inc. | Director | 10 000 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Charles A Baker. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Charles A Baker som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 439 | 7 439 | |||||
2017-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 0 | −100,00 | |||
2017-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 9 000 | −18,18 | 450,00 | −900 000 | 4 050 000 |
2017-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 11 000 | 22,22 | 18,61 | 37 220 | 204 710 |
2017-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 830 | 7 830 | |||||
2016-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 2 000 | −60,00 | |||
2016-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 9 000 | −2,17 | 394,33 | −78 866 | 3 548 970 |
2016-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 9 200 | −6,12 | 393,64 | −236 184 | 3 621 488 |
2016-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 9 800 | −3,92 | 392,41 | −156 964 | 3 845 618 |
2016-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 10 200 | −10,53 | 391,36 | −469 632 | 3 991 872 |
2016-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 11 400 | −5,00 | 390,67 | −234 402 | 4 453 638 |
2016-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 12 000 | 33,33 | 18,61 | 55 830 | 223 320 |
2016-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 9 212 | 9 212 | |||||
2015-09-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 5 000 | −50,00 | |||
2015-09-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 9 000 | −35,71 | 550,00 | −2 750 000 | 4 950 000 |
2015-09-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 14 000 | 55,56 | 18,61 | 93 050 | 260 540 |
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 10 000 | −33,33 | |||
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 9 000 | −2,17 | 457,21 | −91 442 | 4 114 890 |
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 9 200 | −7,07 | 456,36 | −319 452 | 4 198 512 |
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 536 | 9 900 | −13,43 | 455,48 | −699 617 | 4 509 252 |
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 999 | 11 436 | −14,88 | 454,38 | −908 306 | 5 196 290 |
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −265 | 13 435 | −1,93 | 453,71 | −120 233 | 6 095 594 |
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 13 700 | −2,14 | 452,45 | −135 735 | 6 198 565 |
2015-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 14 000 | 55,56 | 18,61 | 93 050 | 260 540 |
2015-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 838 | 10 838 | |||||
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 0 | −100,00 | |||
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 9 000 | −1,10 | 313,40 | −31 340 | 2 820 600 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 9 100 | −6,19 | 312,29 | −187 374 | 2 841 839 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 9 700 | −11,01 | 311,46 | −373 752 | 3 021 162 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 10 900 | −5,22 | 310,80 | −186 480 | 3 387 720 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 11 500 | −3,36 | 308,25 | −123 300 | 3 544 875 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 11 900 | −2,46 | 307,65 | −92 295 | 3 661 035 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 12 200 | −1,61 | 305,25 | −61 050 | 3 724 050 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 12 400 | −2,36 | 304,42 | −91 326 | 3 774 808 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 12 700 | −2,31 | 303,64 | −91 092 | 3 856 228 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 13 000 | −0,76 | 302,90 | −30 290 | 3 937 700 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 13 100 | −5,07 | 301,12 | −210 784 | 3 944 672 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 200 | 13 800 | −42,50 | 300,09 | −3 060 918 | 4 141 242 |
2014-03-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 24 000 | 166,67 | 23,84 | 357 600 | 572 160 |
2014-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 750 | 12 750 | |||||
2014-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −590 | 0 | −100,00 | ||||
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 0 | −100,00 | |||
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 9 000 | −4,26 | 319,13 | −127 652 | 2 872 170 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 9 400 | −6,93 | 318,27 | −222 789 | 2 991 738 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 10 100 | −8,18 | 317,48 | −285 732 | 3 206 548 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 11 000 | −9,84 | 316,54 | −379 848 | 3 481 940 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −800 | 12 200 | −6,15 | 315,51 | −252 408 | 3 849 222 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 608 | 13 000 | −16,71 | 314,31 | −819 720 | 4 086 030 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 705 | 15 608 | −19,18 | 313,47 | −1 161 406 | 4 892 640 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 887 | 19 313 | −16,75 | 312,53 | −1 214 804 | 6 035 892 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 23 200 | −1,28 | 311,59 | −93 477 | 7 228 888 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 23 500 | −0,42 | 309,73 | −30 973 | 7 278 655 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 23 600 | −0,42 | 308,91 | −30 891 | 7 290 276 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 23 700 | −1,25 | 302,46 | −90 738 | 7 168 302 |
2013-10-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 24 000 | 166,67 | 19,69 | 295 350 | 472 560 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 0 | −100,00 | |||
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 9 000 | −3,23 | 257,99 | −77 397 | 2 321 910 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 9 300 | −2,11 | 255,16 | −51 032 | 2 372 988 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −756 | 9 500 | −7,37 | 254,10 | −192 100 | 2 413 950 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −908 | 10 256 | −8,13 | 253,50 | −230 178 | 2 599 896 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 748 | 11 164 | −29,84 | 252,32 | −1 198 015 | 2 816 900 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 938 | 15 912 | −19,84 | 251,67 | −991 076 | 4 004 573 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 150 | 19 850 | −17,29 | 250,06 | −1 037 749 | 4 963 691 |
2013-06-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 24 000 | 166,67 | 15,80 | 237 000 | 379 200 |
2013-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 100 | 0 | −100,00 | |||
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 100 | 0 | −100,00 | |||
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 200 | 1 100 | −52,17 | |||
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 035 | 2 300 | −68,64 | |||
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −6 565 | 7 335 | −47,23 | |||
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 9 590 | −10,29 | 171,45 | −188 595 | 1 644 206 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 100 | 10 690 | 11,47 | 9,17 | 10 087 | 98 027 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 100 | 10 690 | 11,47 | 9,17 | 10 087 | 98 027 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 9 590 | −11,12 | 172,65 | −207 180 | 1 655 714 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 200 | 10 790 | 12,51 | 9,17 | 11 004 | 98 944 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 035 | 9 590 | −34,43 | 173,63 | −874 227 | 1 665 112 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 035 | 14 625 | 52,50 | 9,17 | 46 171 | 134 111 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 565 | 9 590 | −40,64 | 174,46 | −1 145 330 | 1 673 071 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 565 | 16 155 | 68,46 | 9,17 | 60 201 | 148 141 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 9 590 | −10,29 | 175,14 | −192 654 | 1 679 593 |
2012-09-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −13 714 | 0 | −100,00 | |||
2012-09-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 714 | 9 590 | −58,85 | 150,00 | −2 057 100 | 1 438 500 |
2012-09-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 714 | 23 304 | 143,00 | 15,01 | 205 847 | 349 793 |
2012-09-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 286 | 13 714 | −8,57 | |||
2012-09-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 286 | 9 590 | −11,82 | 150,00 | −192 900 | 1 438 500 |
2012-09-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 286 | 10 876 | 13,41 | 15,01 | 19 303 | 163 249 |
2012-06-14 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | 7,93 | 79 300 | 79 300 | ||
2012-04-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −12 910 | 0 | −100,00 | |||
2012-04-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 910 | 9 590 | −57,38 | 125,00 | −1 613 750 | 1 198 750 |
2012-04-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 910 | 22 500 | 134,62 | 18,80 | 242 708 | 423 000 |
2012-04-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 090 | 12 910 | −13,93 | |||
2012-04-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 090 | 9 590 | −17,89 | 125,00 | −261 250 | 1 198 750 |
2012-04-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 090 | 11 680 | 21,79 | 18,80 | 39 292 | 219 584 |
2012-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 535 | 0 | −100,00 | |||
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −715 | 1 535 | −31,78 | |||
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 465 | 2 250 | −39,43 | |||
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 968 | 3 715 | −44,41 | |||
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 071 | 6 683 | −23,66 | |||
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 246 | 8 754 | −12,46 | |||
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 535 | 590 | −72,24 | 15,49 | −23 779 | 9 140 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 535 | 2 125 | 260,17 | 12,00 | 18 420 | 25 500 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −715 | 590 | −54,79 | 15,43 | −11 031 | 9 103 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 715 | 1 305 | 121,19 | 12,00 | 8 580 | 15 660 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 465 | 590 | −71,29 | 15,40 | −22 562 | 9 087 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 465 | 2 055 | 248,31 | 12,00 | 17 580 | 24 660 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 968 | 590 | −83,42 | 15,30 | −45 410 | 9 027 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 968 | 3 558 | 503,05 | 12,00 | 35 616 | 42 696 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 071 | 590 | −77,83 | 15,25 | −31 583 | 8 998 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 071 | 2 661 | 351,02 | 12,00 | 24 852 | 31 932 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 246 | 590 | −67,86 | 15,24 | −18 988 | 8 991 |
2006-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 246 | 1 836 | 211,19 | 12,00 | 14 952 | 22 032 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −500 | 0 | −100,00 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −200 | 500 | −28,57 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 000 | 700 | −58,82 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 000 | 1 700 | −37,04 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −700 | 2 700 | −20,59 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −600 | 3 400 | −15,00 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −500 | 4 000 | −11,11 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −500 | 4 500 | −10,00 | |||
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 590 | −45,87 | 14,71 | −7 355 | 8 679 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 500 | 1 090 | 84,75 | 14,00 | 7 000 | 15 260 | |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 590 | −25,32 | 14,73 | −2 946 | 8 691 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 200 | 790 | 33,90 | 14,00 | 2 800 | 11 060 | |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 590 | −62,89 | 14,76 | −14 760 | 8 708 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 000 | 1 590 | 169,49 | 14,00 | 14 000 | 22 260 | |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 590 | −62,89 | 14,80 | −14 800 | 8 732 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 000 | 1 590 | 169,49 | 14,00 | 14 000 | 22 260 | |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 590 | −54,26 | 14,83 | −10 381 | 8 750 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 700 | 1 290 | 118,64 | 14,00 | 9 800 | 18 060 | |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 590 | −50,42 | 14,84 | −8 904 | 8 756 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 600 | 1 190 | 101,69 | 14,00 | 8 400 | 16 660 | |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 590 | −45,87 | 14,85 | −7 425 | 8 762 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 500 | 1 090 | 84,75 | 14,00 | 7 000 | 15 260 | |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 590 | −45,87 | 14,90 | −7 450 | 8 791 |
2004-02-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 500 | 1 090 | 84,75 | 14,00 | 7 000 | 15 260 | |
2004-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 |